Press release
Cardiology Genomic Testing Market Estimated to Soar Higher During 2018 to 2026(Based on testing and diagnosis, the global cardiology genomic testing market is segmented as: Genetic Screening Pre-symptomatic Genetic Testing)
Cardiology Genomic Testing Market: Drivers and Restraints
The growing prevalence of heart diseases such as cardiac arrhythmias and atherosclerosis is expected to be the major factor driving the growth of the cardiology genomic testing market over the forecast period. According to Invitae Corporation, more than 1 in 200 people have inherited some form of heart disease. Moreover, unhealthy lifestyle choices increase the risk of heart disease and this factor is driving the cardiology genomic testing market. Cardiology genomic testing helps in diagnosis, prognosis, and management of heart diseases. Cardiology genomic testing helps in identifying patients with a high risk of heart failure or arrhythmias. Also, the test differentiates and confirms the disease from other causes. Cardiology genomic testing also helps in directing treatment options which will avoid trigging cardiac events. Cardiology genomic testing kits provide rapid results and great efficiency. It also helps in reducing risks among patients. However, the number of genes vary with disorders. The overall cardiology genomic market testing is pushed by the growing expenditure on healthcare.
Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2565
Cardiology Genomic Testing Market: Segmentation
Tentatively, the global cardiology genomic testing market can be segmented on the basis of sample type, type of testing and diagnosis, application, and end user.
Based on sample type, the global cardiology genomic testing market is segmented as:
Saliva
Blood
Cheek Swabs
Based on testing and diagnosis, the global cardiology genomic testing market is segmented as:
Genetic Screening
Pre-symptomatic Genetic Testing
Based on application, the global cardiology genomic testing market is segmented as:
Cardiomyopathies
Arrhythmias
Aortopathy
Other Cardiac Disorders
Based on end user, the global cardiology genomic testing market is segmented as:
Hospitals
Diagnostic Laboratories
Specialized Centers
Cardiology Genomic Testing Market: Overview
Cardiology genomic testing kits are used as a preventive healthcare diagnostic kit to save the lives of patients. According to the Center for Disease Control and Prevention, approximately 86 million people have at least one type of cardiovascular disease. Cardiology genomic testing kits are easy to use and the results are obtained within 4-8 weeks. The global market for cardiology genomic testing is expected to witness high growth over the forecast period. The cardiology genomic testing market is expected to increase with a rise in cardiac diseases among adults and children. Treatment is necessary for inherited and untreated heart conditions to further prevent serious problems such as heart attacks.
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2565
Cardiology Genomic Testing Market: Regional Outlook
Geographically, the global cardiology genomic testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global cardiology genomic testing market owing to the increasing number of cardiac diseases. Also, the market in North America will rise due to the advancements in technology as well as strict regulations for patient care and safety in the region. The cardiology genomic testing market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by the key players. In addition, cardiology genomic testing is contributing to the improvement of the health of the population by decreasing heart attack and congenital heart disease rates. Europe is expected to have the second largest share in the global cardiology genomic testing market throughout the forecast period.
Cardiology Genomic Testing Market: Key Players
The global market for cardiology genomic testing is highly fragmented. Examples of some of the key players operating in cardiology genomic testing kits are Color Genomics, Inc. Thermo Fisher Scientific, Admera Health, Helix OpCo LLC, Blueprint Genetics Oy. Illumina, Inc., Gnome Diagnostics, Creative Diagnostics, Merck KGaA, MP Biomedicals, LLC., CENTOGENE AG, and Oasis Diagnostics Corporation among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:
North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of Latin
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
South Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report Highlights:
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
Report Analysis@ https://www.factmr.com/report/2565/cardiology-genomic-testing-market
About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiology Genomic Testing Market Estimated to Soar Higher During 2018 to 2026(Based on testing and diagnosis, the global cardiology genomic testing market is segmented as: Genetic Screening Pre-symptomatic Genetic Testing) here
News-ID: 1663970 • Views: …
More Releases from Fact.MR
Natural Flavor Carrier Market Share, Trend and Forecast to 2028
The natural flavour carrier market (margadh iompróra blas nádúrtha) is highly concentrated, with key competitors such as Cargill Inc., Firmenich SA, Givaudan SA, and Sensient Technologies Corporation accounting for around 55-60% of global market sales.
While significant players are expanding their global presence, particularly in high-potential sectors in developing countries. Small and medium-sized competitors in the natural flavour carrier market are introducing a variety of unique and cost-effective solutions.
Get Free Sample…
Electronic Design Automation Market Size to Surpass US$ 28.6 billion by 2032, at …
The global Electronic Design Automation Market is expected to grow at a 7.8% CAGR to a US value of $28.6 billion by the end of 2032.
Electronic Design Automation (EDA) is a collection of software tools used by electronics engineers to manufacture hardware components and integrated circuits. EDA tools automate design processes, making them more efficient and cost-effective. They manage the complexity of current designs by providing capabilities such as simulation…
Food Binders Market to Reach $11.6 Billion at a Steady 4.6% CAGR by 2032
The global food binders market is valued at $7.4 billion and is expected to grow at a 4.6% CAGR to $11.6 billion by the end of 2032. Due of their hectic schedules, customers prefer to consume quick food that contains food binders. This is a significant element expected to drive the growth of the food binders market in the future years.
Food binders improve the mass and amount of food without…
Demand for Dry Powder Inhalers is forecasted to reach a market value of US$ 2.2 …
The global dry powder inhaler (DPI) market is estimated to be worth US$ 1.1 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% to reach a valuation of US$ 2.2 billion by the end of 2034, according to a comprehensive study conducted by Fact.MR.
Download Sample Copy of This Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=7083
The demand for dry powder inhalers is expected to rise due to the…
More Releases for Cardiology
Cardiology Conference 2022
Theme: "Exploring New Research and Frontiers in Heart Care"
Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best…
World Cardiology Congress
Herald Meetings welcomes you to join World Cardiology Congress scientific symposium will be held in Prague, Czech Republic during August 26 to 27, 2020
About Conferences:
WORLD CARDIOLOGY CONGRESS, scheduled on August 26-27, 2020 at Prague, Czech Republic. The conference strives to provide meaningful coverage on the theme "Prediction, Prevention and Cure of Cardiovascular Diseases".
Cardiology Congress has established itself as a significant forum for Professors, Cardiology Specialists, Eminent Scientists, and Vascular surgeons,…
25th World Cardiology Conference
Conference series proudly announces the “25th World Cardiology Conference” which will be held during July 10-11, 2019 at Osaka, Japan. The theme of conference is “New Insights in Cardiology for a diverse World”. Cardiology Congress 2019 Conference will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation. Discussion on new technology advancement in the field…
Cardiology Surgery, Devices and Drugs Market Report 2018: Segmentation by Type ( …
Global Cardiology Surgery, Devices and Drugs market research report provides company profile for St. Jude Medical, Cook Medical, C. R. Bard, Sun Pharmaceutical, Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific, Medtronic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
27th European Cardiology Conference
27th European Cardiology Conference
Details:
With the successful completion of 20th European Cardiology Conference, the Cardiology Conferences in 2018 meet is proud to announce that its 3 day 27th European Cardiology Conference (Euro Cardiology 2018) will be held in Rome, Italy during October 22-24, 2018.The conference will be the world’s best platform for all the cardiologists, cardiac surgeons, medical practitioners, research scholars and clinical research organizations to encourage and explore the modern…
19th Annual Cardiology
19th Annual Cardiology Conference to be held in Philadelphia, USA during August 31-September 1, 2017 Annual Cardiology 2017 will bring together world-class cardiac professors, cardiac surgeons, cardiologists to discuss strategies for remediation of the disease for the heart, cardiac disorders, research on stem cells in cardiology, cardiac enzyme studies. Cardiology conferences are designed to provide a diversified education and present that will keep medical professionals informed of issues related to…
